Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review.
- Published In:
- Obesity pillars, 16, 100209 (2025)
- Database ID:
- RPEP-11640
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11640APA
Johnson, Brittany V B; Milstead, Mary; Kreider, Rachel; Jones, Rachel. (2025). Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review.. Obesity pillars, 16, 100209. https://doi.org/10.1016/j.obpill.2025.100209
MLA
Johnson, Brittany V B, et al. "Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review.." Obesity pillars, 2025. https://doi.org/10.1016/j.obpill.2025.100209
RethinkPeptides
RethinkPeptides Research Database. "Dietary supplement considerations during glucagon-like Pepti..." RPEP-11640. Retrieved from https://rethinkpeptides.com/research/johnson-2025-dietary-supplement-considerations-during
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.